Reducing risk and ensuring safety is our vision af Fera underpinned with decades of experience. We have a wide range of services to help you in the potential to improve animal health, so partnering with a trusted supplier with expertise in veterinary medicine will help you in the development of veterinary pharmaceutical, technical and food products. From our more desk based preliminary risk assessments which are invaluable for designing Phase 2 experimental testing programmes and the early identification of issues to the more comprehensive experimental investigations we carry out in Phase 2 understanding of animal health to our environmental fate modelling, you can feel confident that Fera will help you secure the potential of your products.
At Fera we also offer a range of bespoke studies using our trusted analytical capability to perform studies with radiolabelled or non-radiolabelled test items, giving our customers more flexibility to their ERA approach ensuring compliance with regulatory requirements. As more parent associated metabolite fate studies are required, we have the expertise to tailor the design of the standard OECD studies to meet specific customer needs by adapting the test matrix, design and analysis to suit the analyte in question. Our team of experts support you through the entire regulatory process giving our customers more options to their risk assessment as well as the confidence in asking any questions about compound formulation to regulator queries regarding submitted risk assessments.
To speak with us about our veterinary medicines services, please contact the chemicals team on +44 (0)1904 462514 or e-mail us at
T: +44 (0)300 100 0324
We are the National Reference Laboratory for Veterinary Medicines